Skin absorption databases and predictive equations

Transdermal Drug Delivery, Second Edition: Revised and Expanded

Volumn , Issue , 2002, Pages 57-141

  Vecchia, Brent E ^a,b   Bunge, Annette L ^a  

^a Department of Geology and Geological Engineering   (United States)

^b Blakely Sokoloff Taylor and Zafman LLP   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85056917458     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (96)

1. C Hansch, A Leo, D Hoekman. Exploring QSAR: Hydrophobie, Electronic, and Steric Constants. Washington, DC: American Chemical Society, 1995.
2. PCModel. Ver. 4.2, Daylight Chemical Information Systems, Inc., Mission Viejo, CA, 1995.
3. M Sznitowska, B Berner, HI Maibach. In vitro permeation of human skin by multipolar ions. Int J Pharm 99:43-49, 1993.
4. SD Roy, GL Flynn. Transdermal delivery of narcotic analgesics: pH, anatomical, and subject influences on cutaneous permeability of fentanyl and sufentanil. Pharm Res 7:842-847, 1990.
5. SD Roy, GL Flynn. Transdermal delivery of narcotic analgesics: comparative permeabilities of narcotic analgesics through human cadaver skin. Pharm Res 6:825-832, 1989.
6. RP Schwarzenbach, PM Gschwend, DM Imboden. Environmental Organic Chemistry. New York: John Wiley 1993.
7. SPARC (SPARC Performs Automated Reasoning in Chemistry): An Expert System for Estimating Physical and Chemical Reactivity. Ver. Windows Prototype Version 1.1, US EPA (Ecosystem Research Division) and University of Georgia, Athens, GA. Athens GA, 1995.
8. a’s. QSARDI 14:348-355, 1995.
9. th ed. New York: McGraw-Hill, 1987.
10. HA Sober, ed. Handbook of Biochemistry. Cleveland, OH; Chemical Rubber Company, 1968.
11. rded. New York: Academic Press, 1975.
12. J Crank. The Mathematics of Diffusion. London: Oxford University Press, 1975.
13. GE Parry, AL Bunge, GD Silcox, LK Pershing, DW Pershing. Percutaneous absorption of benzoic acid across human skin. I. In vitro experiments and mathematical modeling. Pharm Res 7:230-236, 1990.
14. RO Potts, RH Guy. Predicting skin permeability. Pharm Res 9:663-669, 1992.
15. M Mulder. Basic Principles of Membrane Technology. Boston: Kluwer Academic, 1991.
16. IH Blank, RJ Scheuplein, DJ Macfarlane. Mechanism of percutaneous absorption III. The effect of temperature on the transport of non-electrolytes across the skin. J Invest Dermatol 49:582-589, 1967.
17. JR Welty, CE Wicks, RE Wilson, eds. Fundamentals of Momentum, Heat, and Mass Transfer. New York: John Wiley, 1986.
18. th ed. New York: McGraw-Hill, 1987.
19. PM Elias. Lipids and the epidermal permeability barrier. Arch Dermatolog Res 270:95-117, 1981.
20. BD Anderson, WI Higuchi, PV Raykar. Heterogeneity effects on permeability-partition coefficient relationships in human stratum corneum. Pharm Res 5:566-573, 1988.
21. GL Flynn. Physicochemical determinants of skin absorption. In: TR Ger-rity, CJ Henry, eds. Principles of Route-to-Route Extrapolation for Risk Assessment. New York: Elsevier, 1990, pp 93-127.
22. GB Kasting, RL Smith, ER Cooper. Effect of lipid solubility and molecular size on percutaneous absorption. In: B Shroot, H Schaefer, eds. Skin Pharmacokinetics. Basel: Karger, 1987, pp 138-153.
23. GB Kasting, RL Smith, BD Anderson. Prodrugs for dermal delivery: solubility, molecular size, and functional group effects. In: KB Sloan, ed. Prodrugs: Topical and Ocular Drug Delivery. New York: Marcel Dekker, 1992, pp 117-161.
24. AS Michaels, SK Chandrasekaran, JE Shaw. Drug permeation through human skin: theory and in vitro experimental measurement. AIChE J 21:985-996, 1975.
25. Y Morimoto, T Hatanaka, K Sugibayashi, H Omiya. Prediction of skin permeability of drugs: comparison of human and hairless rat skin. J Pharm Pharmacol 44:634-639, 1992.
26. CJ Cramer, GR Famini, AH Lowrey. Use of calculated quantum chemical properties as surrogates for solvatochromic parameters in structure-activity relationships. Acc Chem Res 26:599-605, 1993.
27. GR Famini, CA Penski. Using theoretical descriptors in quantitative structure activity relationships: Some physicochemical properties. J Phys Org Chem 5:395-408, 1992.
28. MH Abraham, HS Chadha, GS Whiting, RC Mitchell. Hydrogen bonding part 32. An analysis of water-octanol and water-alkane partitioning and the A log P parameter of Seiler. J Pharm Sci 83:1085-1100, 1994.
29. N El Tayar, RS Tsai, B Testa, PA Carrupt, A Leo. Partitioning of solutes in different solvent systems: the contribution of hydrogen-bonding capacity and polarity. J Pharm Sci 80:590-598, 1991.
30. MH Abraham, HS Chadha, RC Mitchell. The factors that influence skin penetration of solutes. J Pharm Pharmacol 47:8-16, 1995.
31. MH Abraham, JC McGowan. The use of characteristic volumes to measure cavity terms in reversed phase liquid chromatography. Chromatographia23:243-246, 1987.
32. BD Anderson. Department of Pharmaceutics and Pharmaceutical Chemistry, University of Utah, personal communication, 1995.
33. LM Jolicoeur, MR Nassiri, C Shipman, HK Choi, GL Flynn. Etorphine is an opiate analgesic physicochemically suited to transdermal delivery. Pharm Res 9:963-965, 1992.
34. RJ Scheuplein, IH Blank. Permeability of the skin. Physiol Rev 51:702-747, 1971.
35. T Dutkiewicz, H Tyras. A study of the skin absorption of ethylbenzene in man. Br J Ind Med 24:330-332, 1967.
36. T Dutkiewicz, H Tyras. Skin absorption of toluene, styrene, and xylene by man. Br J Ind Med 25:243, 1968.
37. J Hadgraft, G Ridout. Development of model membranes for percutaneous absorption measurements. I. Isopropyl myristate. Int J Pharm 39:149-156, 1987.
38. SD Roy, S-Y Hou, SL Witham, GL Flynn. Transdermal delivery of narcotic analgesics: comparative metabolism and permeability of human cadaver skin and hairless mouse skin. J Pharm Sci 83:1723-1728, 1994.
39. JMP Statistical Discovery Software. Ver. 3.1, SAS Institute, Inc., Cary, North Carolina, 1995.
40. RJ Scheuplein, IH Blank, GJ Brauner, DJ MacFarlane. Percutaneous absorption of steroids. J Invest Dermatol 52:63-70, 1969.
41. O Siddiqui, MS Roberts, AE Polack. Percutaneous absorption of steroids: relative contributions of epidermal penetration and dermal clearance. J Pharmacokinet Biopharm 17:405-424, 1989.
42. BD Anderson, PV Raykar. Solute structure-permeability relationships in human stratum corneum. J Invest Dermatol 93:280-286, 1989.
43. KD Peck, A-H Ghanem, WI Higuchi. The effect of temperature upon the permeation of polar and ionic solutes through human epidermal membranes. J Pharm Sci 84:975-982, 1995.
44. RJ Scheuplein. Mechanism of percutaneous absorption III. The effect of temperature on the transport of nonelectrolytes across the skin. J Invest Dermatol 49:582-589, 1967.
45. P Singh, MS Roberts. Skin permeability and local tissue concentrations of nonsteroidal anti-inflammatory drugs after topical application. J Pharmacol Exp Ther 268:144-151, 1994.
46. DR Lide, ed. CRC Handbook of Chemistry and Physics. Boca Raton, FL: CRC Press, 1996.
47. RL Bronaugh, ER Congdon. Percutaneous absorption of hair dyes: correlation with partition coefficients. J Invest Dermatol 83:124-127, 1984.
48. J Nakai. Health Canada, personal communication, 1995.
49. IH Blank, DJ McAuliffe. Penetration of benzene through human skin. J Invest Dermatol 85:522-526, 1985.
50. MS Roberts. Percutaneous absorption of phenolic compounds. Ph.D. thesis, University of Sydney, Sydney, Australia, 1976.
51. K Kubota, HI Maibach. In vitro percutaneous permeation of betamethasone and betamethasone 17-valerate. J Pharm Sci 82:1039-1045, 1993.
52. MS Roberts, RA Anderson, J Swarbrick. Permeability of human epidermis to phenolic compounds. J Pharm Pharmacol 29:677-683, 1977.
53. RJ Scheuplein, IH Blank. Mechanism of percutaneous absorption. IV. Penetration of nonelectrolytes (alcohols) from aqueous solutions and from pure liquids. J Invest Dermatol 60:286-296, 1973.
54. D Southwell, BW Barry, R Woodford. Variations in permeability of human skin within and between specimens. Int J Pharm 18:299-309, 1984.
55. WR Galey, HK Lonsdale, S Nacht. The in vitro permeability of skin and buccal mucosa to selected drugs and tritiated water. J Invest Dermatol 67: 713-717, 1976.
56. P Liu, WI Higuchi, A-H Ghanem, WR Good. Transport of beta-estradiol in freshly excised human skin in vitro: diffusion and metabolism in each skin layer. Pharm Res 11:1777-1784, 1994.
57. NA Megrab, AC Williams, BW Barry. Oestradiol permeation across human skin, silastic and snake skin membranes—the effects of ethanol water cosolvent systems. Int J Pharm 116:101-112, 1995.
58. IH Blank. Penetration of low-molecular-weight alcohols into skin I. Effect of concentration of alcohol and type of vehicle. J Invest Dermatol 43:415-420, 1964.
59. RC Scott, MA Corrigan, F Smith, H Mason. The influence of skin structure on permeability: an intersite and interspecies comparison with hydrophilic penetrants. J Invest Dermatol 96:921-925, 1991.
60. JR Bond, BW Barry. Hairless mouse skin is limited as a model for assessing the effects of penetration enhancers in human skin. J Invest Dermatol 90: 810-813, 1988.
61. IP Dick, RC Scott. Pig ear skin as an in-vitro model for human skin permeability. J Pharm Pharmacol 44:640-645, 1992.
62. K Sato, K Sugibayashi, Y Morimoto. Species differences in percutaneous absorption of nicorandil. J Pharm Sci 80:104-107, 1991.
63. A Dal Pozzo, G Donzelli, E Liggeri, L Rodriguez. Percutaneous absorption of nicotinic acid derivatives in vitro. J Pharm Sci 80:54-57, 1991.
64. RL Bronaugh, ER Congdon, RJ Scheuplein. The effect of cosmetic vehicles on the penetration of V-nitrosodiethanolamine through excised human skin. J Invest Dermatol 76:94-96, 1981.
65. K Harada, T Murakami, E Kawasaki, Y Higashi, S Yamamoto, N Yata. In-vitro permeability to salicylic acid of human, rodent, and shed snake skin. J Pharm Pharmacol 45:414-418, 1993.
66. ED Barber, NM Teetsel, KF Kolberg, D Guest. A comparative study of the rates of in vitro percutaneous absorption of eight chemicals using rat and human skin. Fundam Appl Toxicol 19:493-497, 1992.
67. RL Bronaugh, RF Stewart, M Simon. Methods for in vitro percutaneous absorption studies. VII. Use of excised human skin. J Pharm Sci 75:1094-1097, 1986.
68. PC Rigg, BW Barry. Shed snake skin and hairless mouse skin as model membranes for human skin during permeation studies. J Invest Dermatol94:235-240, 1990.
69. BW Barry. School of Pharmacy, University of Bradford, personal communication, 1996.
70. JR Bond, BW Barry. Limitations of hairless mouse skin as a model for in vitro permeation studies through human skin: hydration damage. J Invest Dermatol 90:486-489, 1988.
71. PA Cornwell, BW Barry. Sesquiterpene components of volatile oils as skin penetration enhancers for the hydrophilic permeant 5-fluorouracil. J Pharm Pharmacol 46:261-269, 1994.
72. AC Williams, BW Barry. Terpenes and the lipid-protein-partitioning theory of skin penetration enhancement. Pharm Res 8:17-24, 1991.
73. D Dick, KME Ng, DN Sauder, I Chu. In vitro and in vivo percutaneous absorption of 14C-chloroform in humans. Hum Exp Toxicol 14:260-265, 1992.
74. BW Barry, SM Harrison, PH Dugard. Vapour and liquid diffusion of model penetrants through human skin; correlation with thermodynamic activity. J Pharm Pharmacol 37:226-236, 1985.
75. J Swarbrick, G Lee, J Brom, NP Gensmantel. Drug permeation through human skin II: Permeability of ionizable compounds. J Pharm Sci 73:1352-1355, 1984.
76. JE Wahlberg. Percutaneous absorption of sodium chromate (51Cr), cobal-tous (58Co), and mercuric (203Hg) chlorides through excised human and guinea pig skin. Acta Derm Venereol 45:415-426, 1965.
77. WA Ritschel, A Sabouni, AS Hussain. Percutaneous absorption of couma-rin, griseofulvin and propranolol across human scalp and abdominal skin. Methods Find Exp Clin Pharmacol 11:643-646, 1989.
78. M Lodén. The in vitro permeability of human skin to benzene, ethylene, glycol, formaldehyde, and n-hexane. Acta Pharmacol Toxicol 58:382-389, 1986.
79. SD Roy, DJ Chatterjee, E Manoukian, A Divor. Permeability of pure enantiomers of ketorolac through human cadaver skin. J Pharm Sci 84:987-990, 1995.
80. MR Moore, PA Meredith, WS Watson, DJ Sumner, MK Taylor, A Goldberg. The percutaneous absorption of lead-203 in humans from cosmetic preparations containing lead acetate, as assessed by whole-body counting and other techniques. Food Chem Toxicol 18:399-405, 1980.
81. P Singh, MS Roberts. Dermal and underlying tissue pharmacokinetics of lidocaine after topical application. J Pharm Sci 83:774-781, 1994.
82. ZT Chowhan, R Pritchard. Effect of surfactants on percutaneous absorption of naproxen I: comparisons of rabbit, rat, and human excised skin. J Pharm Sci 67:1272-1274, 1978.
83. A Fullerton, JR Andersen, A Hoelgaard. Permeation of nickel through human skin in vitro—effect of vehicles. Br J Dermatol 118:509-516, 1988.
84. MH Samitz, SA Katz. Nickel-epidermal interactions: diffusion and binding. Env Res 11:34-39, 1976.
85. 111 into the resorption of silver through human skin. Acta Derm Venereol 34:415-419, 1954.
86. B Baranowska-Dutkiewicz. Absorption of hexavalent chromium by skin in man. Arch Toxicol 47:47-50, 1981.
87. J Nakai, I Chu, D Moir, RP Moody. Dermal absorption of chemicals into freshly-prepared and frozen human skin, 1995.
88. RL Bronaugh, TJ Franz. Vehicle effects on percutaneous absorption: in vivo and in vitro comparisons with human skin. Br J Dermatol 115:1-11, 1986.
89. RL Cleek, AL Bunge. A new method for estimating dermal absorption from chemical exposure. 1. General approach. Pharm Res 10:497-506, 1993.
90. ED Barber. Health and Environmental Laboratory, Eastman Kodak Company, personal communication, 1996.
91. RL Bronaugh. Food and Drug Administration, personal communication, 1996.
92. MS Roberts. Department of Medicine, The University of Queensland, personal communication, 1996.
93. K Sato, K Sugibayashi, Y Morimoto, H Omiya, N Enomoto. Prediction of the in-vitro human skin permeability of nicorandil from animal data. J Pharm Pharmacol 41:379-383, 1989.
94. C Hansch, A Leo. Exploring QSAR: Fundamentals and Applications in Chemistry and Biology. Washington, D.C.: American Chemical Society, 1995.
95. P Meyer, G Maurer. Correlation and prediction of partition coefficients of organic solutes between water and an organic solvent with a generalized form of the linear solvation energy relationship. Ind Eng Chem Res 34: 373-381, 1995.
96. GL Flynn. College of Pharmacy, University of Michigan, personal communication, 1996.